Research libraryMOLEKUL / SOURCE RECORD

PRIMULA: Rumalon in persistent knee osteoarthritis pain

A. E. Karateev, L. I. Alekseeva, A. M. Lila, et al. · 2018 · Consilium Medicum 20(9), 51–57

Indexed 2026-11-12.

Uncontrolled human reportFull text availableSource linked

Reported findings and study design

Reported findings

Open-label series with assessments at weeks 8 and 12. The Russian protocols used 25 intramuscular injections, starting with 0.3 and 0.5 mL, then 1 mL per injection. The main text specifies three maintenance injections per week.

Dose, route and schedule

Open-label series with assessments at weeks 8 and 12. The Russian protocols used 25 intramuscular injections, starting with 0.3 and 0.5 mL, then 1 mL per injection. The main text specifies three maintenance injections per week.

Protocol source ↗ · Original Russian article, full methods and results

Results · Original Russian article, full methods and results
MeasureResultComparison, timing and statistics
Pain at 12 weeksVisual analog pain score fell 34.6% and WOMAC pain fell 37.2% from baseline (both p<0.001).
Function and stiffness at 12 weeksWOMAC functional impairment fell 30.0%, stiffness 30.4% and the total score 32.4% from baseline.
Medication use and adverse events31.7% stopped NSAIDs. Adverse events were reported in 1.8%, with no resulting interruptions of Rumalon.

The study had no comparison arm. Changes from baseline include the effects of concurrent care and time.

Source for these results ↗ · Reviewed 2026-11-12

For research and education. Consult a qualified clinician for medical advice.

Study limitations and source details

Study limitations

  • The study had no comparison arm. Changes from baseline include the effects of concurrent care and time.

Source access

Original Russian article, full methods and results

Source reviewed 2026-11-12.

Open source ↗

DOI: 10.26442/2075-1753_2018.9.51-57

Citation and original source

Original source: A. E. Karateev, L. I. Alekseeva, A. M. Lila, et al.. PRIMULA: Rumalon in persistent knee osteoarthritis pain Consilium Medicum 20(9), 51–57 2018.

Molekul research summary: https://molekul.io/research/rumalon-primula-2018. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards